These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 33244496)
1. SUCCESSFUL REIMPLEMENTATION OF A VERY LOW CARBOHYDRATE KETOGENIC DIET AFTER SGLT2 INHIBITOR ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS. Fieger EI; Fadel KM; Modarres AH; Wickham EP; Wolver SE AACE Clin Case Rep; 2020; 6(6):e330-e333. PubMed ID: 33244496 [TBL] [Abstract][Full Text] [Related]
2. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature. Mistry S; Eschler DC AACE Clin Case Rep; 2021; 7(1):17-19. PubMed ID: 33851013 [TBL] [Abstract][Full Text] [Related]
3. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report]. Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745 [TBL] [Abstract][Full Text] [Related]
4. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report. Sarno MJF; Hernandez DPF; Matulac MO Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642 [TBL] [Abstract][Full Text] [Related]
5. Delayed euDKA Associated With Dapagliflozin After Pancreatitis. Wu G; Wu S; Tang J; Wu H Clin Ther; 2023 Jul; 45(7):e167-e170. PubMed ID: 37248092 [TBL] [Abstract][Full Text] [Related]
6. A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet. Dorcely B; Nitis J; Schwartzbard A; Newman JD; Goldberg IJ; Sum M Curr Diabetes Rev; 2021; 17(2):243-246. PubMed ID: 32178617 [TBL] [Abstract][Full Text] [Related]
7. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis Followed by Excessively Low Carbohydrate Diet. Tsutsui E; Hoshina Y; Homma H Cureus; 2021 Jul; 13(7):e16085. PubMed ID: 34345561 [TBL] [Abstract][Full Text] [Related]
8. Severe euglycemic diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor: case report and literature review. El Ess MS; ElRishi MA Ann Med Surg (Lond); 2023 May; 85(5):2097-2101. PubMed ID: 37228937 [TBL] [Abstract][Full Text] [Related]
10. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature. Gajjar K; Luthra P Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148 [TBL] [Abstract][Full Text] [Related]
11. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report. Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104 [TBL] [Abstract][Full Text] [Related]
12. Fall, Fracture, and Two Episodes of Euglycemic Diabetic Ketoacidosis. Wasey W; Hutchings S; Dufner A; Okon D; Saleh S Cureus; 2022 Jun; 14(6):e25788. PubMed ID: 35812537 [TBL] [Abstract][Full Text] [Related]
13. The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage. Bińczyk W; Dróżdż O; Siudek B; Głuszczyk AM; Plizga JI; Grajnert FJ Eur J Case Rep Intern Med; 2024; 11(6):004567. PubMed ID: 38846667 [TBL] [Abstract][Full Text] [Related]
14. Postoperative extremity gangrene in a patient with type 2 diabetes taking SGLT2 inhibitors: A case report. Wong YC; Liu KL; Lee CL Medicine (Baltimore); 2021 Apr; 100(16):e25590. PubMed ID: 33879720 [TBL] [Abstract][Full Text] [Related]
15. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors. Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255 [TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Menghoum N; Oriot P; Hermans MP Diabetes Metab Syndr; 2021; 15(6):102275. PubMed ID: 34562870 [TBL] [Abstract][Full Text] [Related]
17. Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor. Alhemeiri M; Alseddeeqi E Case Rep Endocrinol; 2022; 2022():4101975. PubMed ID: 35282610 [TBL] [Abstract][Full Text] [Related]